Scancell Signs Agreement with Major International Biotechnology Company to Evaluate an Antibody in the Glymab® Portfolio To download click here Wednesday 12 June 2024 16:45 Categories: GlyMab News Regulatory News Year - 2024
Scancell announces positive response in COVIDITY trial To download click here Monday 13 February 2023 09:08 Categories: GlyMab Year - 2023
Scancell signs Commercial License Agreement with Genmab To download click here Tuesday 25 October 2022 11:48 Categories: GlyMab News Regulatory News Year - 2022
Scancell to produce and clinically validate T cell redirecting bispecific antibodies To download click here Thursday 23 June 2022 10:38 Categories: GlyMab News Regulatory News Year - 2022
Scancell progresses its new anti-glycan monoclonal antibody (mAb) platform GlyMab™ To download click here Thursday 17 March 2022 17:08 Categories: GlyMab Year - 2022